Open AccessExpression of excision repair cross-complementation group 1 in locoregionally advanced nasopharyngeal carcinoma treated with cisplatin-based induction chemotherapy
Author(s) -
Chuan Shen,
Lingling Chen,
Jiangtao Fu,
Haoran Lin
Publication year - 2016
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.191636
Subject(s) - cisplatin , nasopharyngeal carcinoma , induction chemotherapy , medicine , chemotherapy , complementation , oncology , cancer research , biology , gene , radiation therapy , genetics , phenotype
The purpose of this study was to evaluate the expression of excision repair cross-complementation group 1 (ERCC1) in locoregionally advanced nasopharyngeal carcinoma (NPC) treated with cisplatin-based induction chemotherapy.